spacer
home > > spring 2002 > alternatives to animals for toxicity testing
PUBLICATIONS


Alternatives to Animals for Toxicity Testing

Following recent media coverage and the activities of various animal activist organisations, nowadays most people will have an opinion regarding animal rights, either in relation to fox hunting, farming or on the use of animals in scientific experiments. Some people view this sort of treatment of living creatures as unnecessarily cruel, although their opinion may be modified depending on how well informed they are on the subject.

Animal experimentation is generally regarded as a necessary evil that enables society to benefit from the many advances in scientific knowledge, which have come about in the last hundred years. Animal experimentation has mainly centred on medical research leading to the development of new drugs, vaccines and medical devices where the use of animals has been easier to justify. However, in our modern world we have become increasingly dependent on a massive range of other products derived from the chemical industry, which we demand must be as safe as possible.

The safety assessment of these chemicals, which include pharmaceuticals, agrochemicals, biocides, industrial and household chemicals (including toiletries and cosmetics), is required by law and involves determining a material's toxicological properties, often requiring the use of experimental animals. The aim of this is to determine whether there will be any possible adverse effects in humans. By using these animal models as biological systems, it is possible to ensure that only 'safe' products are introduced into the marketplace.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By C Deegan and M Thomas of SafePharm Laboratories

The toxicology department at SafePharm Laboratories Ltd has been exploring the various animal alternative toxicological tests for a number of years and is active in the promotion of such available tests for hazard assessment.

spacer
C Deegan
spacer
spacer
spacer
M Thomas
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Hope for a new treatment for the autoimmune neuromuscular disease Myasthenia Gravis (MG)

- The biotech companies 3P Biopharmaceuticals and Toleranzia collaborate for that MG treatment - MG is an orphan disease which has a major unmet medical need and a large market potential - The drug candidate,TOL2, has already achieved several positive preclinical results
More info >>

White Papers

e-tools enhance clinical trial performance

e-novex

In today’s ever-evolving medical business, technological changes require innovation to meet growing market demands and to bring about advances in the industry. One such development currently taking place in the field of clinical research is how e-tools are initiating a boost in the productivity of clinical trials.
More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement